Atlas Trials

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

RecordFirmDate
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT03904693)Actelion2019-07-29

Track Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) automatically

Every clearance here is in the API, with alerts when new ones post.